| |
original article |
Journal |
Date |
Title |
Authors All Authors |
| 1 |
[GO] |
Innovative medicine of Kuban |
2025―May―22 |
Validation of Ultrasonographic Criteria for Diagnosing Сlostridioides difficile Colitis in COVID-19 and Non-COVID-19 Patients With Antibiotic-Associated Diarrhea |
I. A. Rutskaya, S. I. Pimanov |
| 2 |
[GO] |
Innovative medicine of Kuban |
2024―Mar―05 |
Pulmonary Sequelae of COVID-19 in Patients With Lung Damage Over 75% (CT-4) |
K. V. Komissarova, A. V. Godzenko, D. A. Doroshenko, I. G. Gordeev, O. V. Averkov, V. I. Vechorko |
| 3 |
[GO] |
Innovative medicine of Kuban |
2023―Mar―09 |
Cluster Analysis Results for Assessment of COVID-19-Related Mortality Differences Between Russian Regions |
V. T. Korkhmazov, V. I. Perkhov |
| 4 |
[GO] |
Innovative medicine of Kuban |
2022―Nov―25 |
Gender and age structure of mortality caused by COVID-19 |
V. T. Korkhmazov, S. N. Alekseenko, V. I. Perkhov |
| 5 |
[GO] |
Innovative medicine of Kuban |
2022―Sep―22 |
COVID-19 impact on hospitalization outcomes of patients with circulatory system diseases |
V. T. Korkhmazov |
| 6 |
[GO] |
Innovative medicine of Kuban |
2022―Jun―27 |
The excess mortality connected with COVID-19 pandemic |
V. T. Korkhmazov |
| 7 |
[GO] |
Innovative medicine of Kuban |
2022―Mar―30 |
Availability of specialized medical care in cases of severe head injuries during the COVID-19 pandemic |
V. T. Korkhmazov, V. I. Perkhov |
| 8 |
[GO] |
Innovative medicine of Kuban |
2022―Mar―30 |
Features of the course of coronavirus infection in patients after thoracic and cardiac surgery |
V. A. Porhanov, I. S. Kazimirov, Z. G. Tatarintseva, V. V. Shtraub, V. E. Kholodova, A. A. Khalafyan |
| 9 |
[GO] |
Innovative medicine of Kuban |
2021―Jun―21 |
Extracorporeal membrane oxygenation in the complex therapy for septic shock in a patient with severe lung damage caused by COVID-19 |
E. A. Popov, V. A. Koriachkin, I. Yu. Sholin, A. A. Savenkov, V. A. Porhanov |
| 10 |
[GO] |
Innovative medicine of Kuban |
2021―Jun―21 |
COVID-19 after emergency coronary artery bypass grafting: features of the postoperative course and prognosis |
Z. G. Tatarintseva, E. D. Kosmacheva, N. V. Chumachenko, A. A. Khalafyan |
| 11 |
[GO] |
Innovative medicine of Kuban |
2020―Jun―03 |
PATHOGENETIC RATIONALE FOR THE USE OF СELL THERAPY IN LUNG INJURY ASSOCIATED WITH SARS-COV-2 |
A. I. Stukan, I. V. Gilevich, V. A. Porhanov, V. N. Bodnya |
